In response to the evolving COVID-19 pandemic, Integral Molecular has adapted its SARS-CoV-2 reporter virus particle (RVP) technology to reflect emerging virus variants, enabling safe laboratory testing for viral resistance to vaccines and drugs.

Integral Molecular

Philadelphia

Integral Molecular startup from Philadelphia, United States is ranked null out of 2449 worldwide and null from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map